Date of publication: October 28, 2021

Decision of the Secretary of Health: Approved

Pursuant to the role of the Health Technology Assessment Council (HTAC) to develop coverage recommendations particularly in the selection and financing of COVID-19 vaccines using the Evaluation Framework set by the HTAC, this report presents all currently available evidence considered in the assessment of COVID-19 Pediatric Vaccination. This assessment follows the HTAC evaluation framework to assess COVID-19 vaccines using the following criteria: (1) responsiveness to magnitude and severity; (2) clinical efficacy and safety; (3) affordability and viability; (4) household financial impact; (5) social impact; and (6) responsiveness to equity.

 

Link to Issuance: https://hta.doh.gov.ph/2021/10/22/department-circular-no-2021-0468-health-technology-assessment-council-htac-recommendations-on-covid-19-vaccination-of-the-pediatric-population/

Evidence summary: https://bit.ly/HTACRecomm-PediaVacc2022

 

HTAC Updated Recommendation Preview:

Vax-2022-Pedia-ES_For-HTAC-RECOMM